Emcure Pharmaceuticals consolidated net profit rises 42.05% in the June 2026 quarter

Sales rise 22.85% to Rs 2580.45 crore

Net profit of Emcure Pharmaceuticals rose 42.05% to Rs 293.98 crore in the quarter ended June 2026 as against Rs 206.95 crore during the previous quarter ended June 2025. Sales rose 22.85% to Rs 2580.45 crore in the quarter ended June 2026 as against Rs 2100.54 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2580.45	2100.54	23
OPM %	20.64	19.84	-
PBDT	503.03	393.71	28
PBT	393.53	294.26	34
NP	293.98	206.95	42

Powered by Capital Market - Live News